Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
BCR/ABL confers growth factor independence upon a murine myeloid cell line.
Mandanas RA, Boswell HS, Lu L, Leibowitz D. Mandanas RA, et al. Leukemia. 1992 Aug;6(8):796-800. Leukemia. 1992. PMID: 1379313
Role of p21 RAS in p210 bcr-abl transformation of murine myeloid cells.
Mandanas RA, Leibowitz DS, Gharehbaghi K, Tauchi T, Burgess GS, Miyazawa K, Jayaram HN, Boswell HS. Mandanas RA, et al. Blood. 1993 Sep 15;82(6):1838-47. Blood. 1993. PMID: 7691239
Dose escalation study of high-dose carboplatin and etoposide with autologous bone marrow support in patients with recurrent and refractory germ cell tumors.
Broun ER, Nichols CR, Mandanas R, Salzman D, Turns M, Hromas R, Cornetta K, Einhorn LH. Broun ER, et al. Bone Marrow Transplant. 1995 Sep;16(3):353-8. Bone Marrow Transplant. 1995. PMID: 8535306 Clinical Trial.
Carboplatin (CBDCA) plus alpha interferon in metastatic non-small cell lung cancer. A Hoosier Oncology Group phase II trial.
Mandanas R, Einhorn LH, Wheeler B, Ansari R, Lutz T, Miller ME. Mandanas R, et al. Am J Clin Oncol. 1993 Dec;16(6):519-21. doi: 10.1097/00000421-199312000-00012. Am J Clin Oncol. 1993. PMID: 8256769 Clinical Trial.
A phase II open-label trial of bortezomib in patients with multiple myeloma who have undergone an autologous peripheral blood stem cell transplant and failed to achieve a complete response.
Rifkin RM, Greenspan A, Schwerkoske JF, Mandanas RA, Stephenson JJ, Kannarkat GT, Zhan F, Boehm KA, Asmar L, Beveridge R. Rifkin RM, et al. Among authors: mandanas ra. Invest New Drugs. 2012 Apr;30(2):714-22. doi: 10.1007/s10637-010-9556-6. Epub 2010 Oct 12. Invest New Drugs. 2012. PMID: 20938715 Clinical Trial.
Pegfilgrastim appears equivalent to daily dosing of filgrastim to treat neutropenia after autologous peripheral blood stem cell transplantation in patients with non-Hodgkin lymphoma.
Rifkin R, Spitzer G, Orloff G, Mandanas R, McGaughey D, Zhan F, Boehm KA, Asmar L, Beveridge R. Rifkin R, et al. Clin Lymphoma Myeloma Leuk. 2010 Jun;10(3):186-91. doi: 10.3816/CLML.2010.n.029. Clin Lymphoma Myeloma Leuk. 2010. PMID: 20511163 Clinical Trial.
High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables.
Beyer J, Kramar A, Mandanas R, Linkesch W, Greinix A, Droz JP, Pico JL, Diehl A, Bokemeyer C, Schmoll HJ, Nichols CR, Einhorn LH, Siegert W. Beyer J, et al. J Clin Oncol. 1996 Oct;14(10):2638-45. doi: 10.1200/JCO.1996.14.10.2638. J Clin Oncol. 1996. PMID: 8874322
Long-term results of autologous marrow transplantation for relapsed or refractory male or female germ cell tumors.
Mandanas RA, Saez RA, Epstein RB, Confer DL, Selby GB. Mandanas RA, et al. Bone Marrow Transplant. 1998 Mar;21(6):569-76. doi: 10.1038/sj.bmt.1701132. Bone Marrow Transplant. 1998. PMID: 9543060 Free article. Clinical Trial.
Autologous bone marrow transplantation for non-Hodgkin lymphoma.
Saez RA, Slease RB, Selby GB, Puckett C, Epstein RB, Mandanas RA, Confer DL. Saez RA, et al. Among authors: mandanas ra. J Okla State Med Assoc. 1994 Aug;87(8):358-63. J Okla State Med Assoc. 1994. PMID: 7931773 Clinical Trial.
Autologous bone marrow transplantation for metastatic breast cancer.
Saez RA, Selby GB, Slease RB, Epstein RB, Mandanas RA, Confer DL. Saez RA, et al. Among authors: mandanas ra. J Okla State Med Assoc. 1994 Sep;87(9):405-10. J Okla State Med Assoc. 1994. PMID: 7996314
18 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback